After years of waiting and millions of men affected, a more localized and targeted solution is finally here: a treatment for baldness is now available in pharmacies. Goodbye pills, hello spray.
A Concrete Hope for Men Affected by Baldness
The name of this new treatment? Fincrezo. It has made a notable debut in French pharmacies. Designed for men aged 18 to 41 suffering from androgenetic alopecia (hereditary baldness), it stands out by its topical form: a spray to be applied directly to the scalp.
Gone are the finasteride tablets, which have long been criticized for their systemic side effects. With Fincrezo, the molecule is the same, but its targeted application limits its distribution in the body. The Bailleul laboratory claims a 100 times reduced exposure compared to oral treatments. This is a small revolution for those concerned about side effects.
This new formula also addresses a strong psychological need: to regain control over one’s appearance using a visible, tangible product that easily fits into a daily routine, much like a shampoo or a hair lotion. This may be its true strength.
How to Use This New Treatment?
Fincrezo comes in the form of a spray with a pump bottle, equipped with a cone to better target the affected areas. During the first use, it is necessary to prime the bottle, then apply between 1 to 4 sprays per day, according to medical recommendations.
Each spray delivers a precise dose of the product to the balding area. Consistency is essential: the treatment only shows visible effects after several weeks or even months. Therefore, patience is required.
However, be cautious: this product is not reimbursed by health insurance. Its price remains reasonable (around 30 to 40 euros per month), but access remains entirely the patient’s responsibility. Many are willing to bear this cost if the results meet expectations.
Another important precaution:
- Do not use in the presence of children or pregnant women.
- The molecule can be absorbed through the skin and cause serious side effects for them.
This treatment is not trivial: its use should remain medically supervised, and a consultation with a dermatologist is highly recommended before starting.
Side Effects: Is the Spray Really Safer?
Changing the route of administration does not mean absence of risk. The ANSM (National Agency for the Safety of Medicines) reminded us in an update from October 2024 that finasteride, even in local application, can lead to:
- Anxiety, depression, or even suicidal thoughts,
- Sexual dysfunction: decreased libido, erectile dysfunction, persistent issues.
The link between topical use and side effects is still under evaluation, but doctors must remain vigilant. Any onset of symptoms should trigger immediate discontinuation of the treatment.
Isolated cases reported in other countries (like Italy or Spain) show that even in cutaneous form, the product can penetrate the skin barrier and have a systemic action, albeit less than in tablet form. Regular medical follow-up is, therefore, a prerequisite for safe use.
A Turning Point in the Fight Against Hair Loss?
The arrival of Fincrezo marks a symbolic advancement: it is the first topical treatment based on finasteride authorized in France. It opens a new avenue for men who wished to try treatment without taking the step towards pills.
However, its success will depend on both its effectiveness and its tolerance. Dermatologists and pharmacists will play a key role in guiding patients through this new protocol. The general public remains poorly informed, and support is still essential.
The Bailleul laboratory is focusing on discreet but targeted communication with health professionals. The goal is to reassure without overselling and to position this product in a serious care approach, rather than as a miracle promise.
For those suffering from baldness, this may finally be a compromise between performance and safety. But one thing is clear: the battle for hair has never been more open, and this launch could be followed by other similar innovations in the years to come.
